Failure of Donor Lymphocyte Infusion to Prevent Graft Rejection in Dogs Given DLA-Identical Marrow after 1 Gy of Total Body Irradiation

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 8, 2006, Pages 813-817

  Baron, Frédéric ^a,c   Sandmaier, Brenda M ^a,b   Zellmer, Eustacia ^a   Sorror, Mohamed ^a   Storer, Barry ^a,b   Storb, Rainer ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Chimerism; Dog; Donor lymphocyte infusion; Hematopoietic cell transplantation; Nonmyeloablative; Pentostatin

Indexed keywords

CYCLOSPORIN; LEUKOCYTE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOSTATIN; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; CONTROLLED STUDY; DIARRHEA; DOG; EXPERIMENTAL MODEL; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; INTUSSUSCEPTION; LEUKOPENIA; LYMPHOCYTE COUNT; LYMPHOCYTE TRANSFUSION; LYMPHOCYTOPENIA; NONHUMAN; POLYMERASE CHAIN REACTION; PROBABILITY; RADIATION DOSE; T LYMPHOCYTE; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME; WEIGHT REDUCTION; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; DOGS; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOSUPPRESSION; LYMPHOCYTE TRANSFUSION; MODELS, ANIMAL; TIME FACTORS; WHOLE-BODY IRRADIATION;

EID: 33746056475     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.05.001     Document Type: Article

References (24)

1. Bornhauser M., Thiede C., Platzbecker U., et al. Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients. Clin Cancer Res. 7 (2001) 2254-2262
2. Maris M.B., Niederwieser D., Sandmaier B.M., et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 102 (2003) 2021-2030
3. Baron F., Maris M.B., Storer B.E., et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia. Biol Blood Marrow Transplant. 11 (2005) 272-279
4. Hallemeier C. Re. High rate of graft failure in 25 patients with chronic myelogenous leukemia conditioned with a reduced-intensity regimen of 550-cGy total body irradiation and cyclophosphamide for unrelated donor transplantation. [letter]. Biol Blood Marrow Transplant. 10 (2004) 726-727
5. McSweeney P.A., Niederwieser D., Shizuru J.A., et al. Hematopoietic cell transplantation in older patients with hematologic malignancies. replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97 (2001) 3390-3400
6. Baron F., Baker J.E., Storb R., et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 104 (2004) 2254-2262
7. Matthes-Martin S., Lion T., Haas O.A., et al. Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning. potential predictive value of NK cell chimaerism for late graft rejection. Leukemia 17 (2003) 1934-1942
8. Storb R., Yu C., Wagner J.L., et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89 (1997) 3048-3054
9. Hogan W.J., Little M.T., Zellmer E., et al. Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates. Biol Blood Marrow Transplant. 9 8 (2003) 489-495 Aug;
10. Baron F., and Storb R. Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders. [review]. Mol Ther. 13 (2006) 26-41
11. Storb R., Yu C., Barnett T., et al. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation. Blood 94 (1999) 1131-1136
12. Storb R., Yu C., Zaucha J.M., et al. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100-cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 94 (1999) 2523-2529
13. Zaucha J.M., Zellmer E., Georges G., et al. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients. CD3 cells are required. Biol Blood Marrow Transplant. 7 (2001) 613-619
14. Diaconescu R., Little M.-T., Leisenring W., et al. What role is there for antithymocyte globulin in allogeneic nonmyeloablative canine hematopoietic cell transplantation?. Biol Blood Marrow Transplant. 11 (2005) 335-344
15. Burroughs L., Mielcarek M., Little M.-T., et al. Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral blood mononuclear cells in a canine transplantation model. Blood 106 (2005) 4002-4008
16. Panse J.P., Storb R., Storer B., et al. Prolonged allogeneic marrow engraftment following nonmyeloablative conditioning using 100-cGy total body irradiation and pentostatin before and pharmocological immunosuppression after transplantation. Transplantation 80 (2005) 1518-1521
17. Dey B.R., McAfee S., Colby C., et al. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation. Biol Blood Marrow Transplant. 9 (2003) 320-329
18. Bethge W.A., Hegenbart U., Stuart M.J., et al. Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning. Blood 103 (2004) 790-795
19. Bolanos-Meade J., Jacobsohn D.A., Margolis J., et al. Pentostatin in steroid-refractory acute graft-versus-host disease. J Clin Oncol. 23 (2005) 2661-2668
20. Bagasra O., Howeedy A., and Pomerantz R.J. Adenosine-deaminase-associated immunodeficiency. I. Differential sensitivities of lymphocyte subpopulations exposed to 2-deoxycoformycin in vivo. Clin Exp Immunol. 88 (1992) 383-388
21. Georges G.E., Storb R., Thompson J.D., et al. Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation. Blood 95 (2000) 3262-3269
22. + regulatory T cells (Treg) block alloreactive host anti-donor T cells in canine mixed hematopoietic chimeras. [abstract]. Blood 106 Pt 1 (2005) 867a
23. Blanco B., Pérez-Simón J.A., Sánchez-Abarca L.I., et al. Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines. Blood 107 (2006) 3575-3583
24. Yamada A., Salama A.D., Sho M., et al. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. J Immunol. 174 (2005) 1357-1364